James T. Secrest, M.S., D.C.
Dr. James T. Secrest, BS, D.C., is a highly accomplished scientist and entrepreneur with extensive expertise in molecular imaging, space biotechnology, and drug safety evaluation. With over two decades of experience spanning research, development, and leadership roles, Dr. Secrest has played a pivotal role in advancing innovative technologies and healthcare solutions.
As the Co-founder and CEO of BioGravity, LLC, Dr. Secrest spearheaded groundbreaking research in microgravity biology, focusing on developing novel therapies for oncology, stem cell treatments, and biomanufacturing in space. His leadership extended to partnerships with global institutions, including the University of Technology Sydney, where he advanced the application of microgravity to medical innovations.
Dr. Secrest’s professional journey includes serving as Senior Manager of Translational Bioimaging at Agensys (Astellas Pharma), where he developed cutting-edge molecular imaging probes and optimized multimodal preclinical imaging laboratories. He also led international business development efforts at Charles River Laboratories and MPI Research, expanding the reach of advanced scientific services across Asia-Pacific, South America, and Africa.
Certified in Project+ CompTIA® and holding a Doctorate of Chiropractic Medicine from Cleveland Chiropractic College, Dr. Secrest combines a robust academic foundation with an exceptional ability to lead cross-functional teams. His expertise spans radiopharmaceutical development, regulatory toxicology, and business strategy.
An accomplished author and presenter, Dr. Secrest has contributed to numerous peer-reviewed publications and international conferences, showcasing his insights on molecular imaging, pharmacology, and space biology. Beyond his scientific contributions, he is deeply committed to environmental sustainability, promoting innovative solutions in renewable energy, aquaponics, and reforestation.
Dr. Secrest continues to influence the forefront of science and technology, serving as a trusted advisor to global biotech initiatives and fostering advancements that bridge cutting-edge research with practical applications to improve human health and well-being.
